Follow us for updates
© 2020
Read the Story →

PH Now Part of WHO's Collaborative Effort to Find COVID-19 Cure

WHO gives PH's Single Joint Research Ethics Board (SJREB) green light to join medical trials
by the staff
Apr 23, 2020

THE Philippines is now a part of the World Health Organization's collaborative effort to find a cure for the global COVID-19 pandemic.

Department of Health (DOH) undersecretary Maria Rosario Vergeire shared that the WHO has given the country's Single Joint Research Ethics Board (SJREB) the green light to join in the trials in developing an effective treatment to combat the virus last April 17.

More than 100 countries have participated in the project.

Vergeire added that the DOH is looking at conducting trials across 20 hospitals nationwide, which will involve at least 500 patients.

The tests are expected to start on Friday.

"Magbibigay kami ng information bukas kung talagang nakumpleto namin ang lahat ng dokumentong kailangan para makapagumpisa bukas yung trial," she said in her online press briefing on Thursday.

The test, to be spearheaded by SJREB, will be in conjuction with the WHO's global search for the cure against the coronavirus.

Four different combinations will be tested in the procedure: remdesivir, a combination of lopinavir and ritonavir, another combination of lopinavir and ritonavir plus interferon beta, and chloroquine.

Continue reading below ↓

Their effectiveness will be compared to the current cure used by the hospitals treating the COVID-19 patients in the country.

Latest Headlines
more about:
Read Next
Recent News
The Dacera family awaits the results of a criminal investigation.
Reports said he's been battling COVID-19.
Five things you need to know about the starmaker.
Trace, test properly, Mayor Magalong Says.
The news. So what? Subscribe to the newsletter that explains what the news means for you.
The email address you entered is invalid.
Thank you for signing up to On Three, reportr's weekly newsletter delivered to your mailbox three times a week. Only the latest, most useful and most insightful reads.
By signing up to newsletter, you agree to our Terms of Service and Privacy Policy.